Literature DB >> 19088484

A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (the Bambuí Study).

M Fernanda Lima-Costa1, Erico Castro-Costa, Elizabeth Uchôa, Joselia Firmo, Antonio Luiz P Ribeiro, Cleusa P Ferri, Martin Prince.   

Abstract

BACKGROUND: Limited clinical data suggest that chronic Trypanosoma cruzi infection, which causes Chagas' disease (ChD), is associated with cognitive impairment. This study investigated this association in a large population-based sample of older adults.
METHODS: Participants in this cross-sectional study comprised 1,449 persons aged > or = 60 years from a Brazilian endemic area (Bambuí). Cognitive functioning was ascertained by the Mini-Mental State Examination (MMSE), considering its score in percentiles [< or =14 (<5th percentile), 15-22 (5th to <25th) and > or =23]. Hypothesized risk factors were T. cruzi infection, ChD-related electrocardiographic (ECG) abnormalities and use of digoxin medication. Potential confounders included depressive symptoms, smoking, stroke, hemoglobin, HDL cholesterol, blood glucose, systolic blood pressure, and use of psychoactive medication.
RESULTS: The prevalence of T. cruzi infection was 37.6%. There was a graded and independent association between infection and the MMSE score (adjusted odds ratios estimated by ordinal logistic regression = 1.99; 95% CI 1.43-2.76). No significant associations between the MMSE score and ECG abnormalities or digoxin medication use were found.
CONCLUSIONS: This study provides for the first time epidemiological evidence of an association between T. cruzi infection and cognitive impairment which was not mediated by either ChD-related ECG abnormalities or digoxin medication use. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19088484      PMCID: PMC2790770          DOI: 10.1159/000182819

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  41 in total

1.  The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.

Authors:  Marianne Pirard; Naomi Iihoshi; Marleen Boelaert; Paulino Basanta; Freddy López; Patrick Van der Stuyft
Journal:  Transfusion       Date:  2005-04       Impact factor: 3.157

2.  Cardiac M(2) muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia.

Authors:  J C Goin; E S Borda; S Auger; R Storino; L Sterin-Borda
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

3.  Diagnostic electrocardiography in epidemiological studies of Chagas' disease: multicenter evaluation of a standardized method.

Authors:  J O Lázzari; M Pereira; C M Antunes; A Guimarães; A Moncayo; R Chávez Domínguez; O Hernández Pieretti; V Macedo; A Rassi; J Maguire; A Romero
Journal:  Rev Panam Salud Publica       Date:  1998-11

Review 4.  [Natural history of Chagas disease].

Authors:  J C Pinto Dias
Journal:  Arq Bras Cardiol       Date:  1995-10       Impact factor: 2.000

Review 5.  Risk factors, outcomes, and stroke subtypes for ischemic stroke.

Authors:  R L Sacco
Journal:  Neurology       Date:  1997-11       Impact factor: 9.910

6.  Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease.

Authors:  Francisco Javier Carod-Artal; Antonio Pedro Vargas; Thomas Anthony Horan; Luiz Guillerme Nadal Nunes
Journal:  Stroke       Date:  2005-04-21       Impact factor: 7.914

7.  Major depression in a population of demented and nondemented older people: prevalence and correlates.

Authors:  Y Forsell; B Winblad
Journal:  J Am Geriatr Soc       Date:  1998-01       Impact factor: 5.562

8.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

Review 9.  The age-dependent relation of blood pressure to cognitive function and dementia.

Authors:  Chengxuan Qiu; Bengt Winblad; Laura Fratiglioni
Journal:  Lancet Neurol       Date:  2005-08       Impact factor: 44.182

10.  Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults.

Authors:  M J Prince; A S Bird; R A Blizard; A H Mann
Journal:  BMJ       Date:  1996-03-30
View more
  8 in total

Review 1.  Neurologic manifestations of Chagas disease.

Authors:  Marco Oliveira Py
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

Review 2.  Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death.

Authors:  Antonia Pino-Marín; Germán José Medina-Rincón; Sebastian Gallo-Bernal; Alejandro Duran-Crane; Álvaro Ignacio Arango Duque; María Juliana Rodríguez; Ramón Medina-Mur; Frida T Manrique; Julian F Forero; Hector M Medina
Journal:  Pathogens       Date:  2021-04-22

3.  Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.

Authors:  Glaucia Vilar-Pereira; Leda Castaño Barrios; Andrea Alice da Silva; Angelica Martins Batista; Isabela Resende Pereira; Otacílio Cruz Moreira; Constança Britto; Hílton Antônio Mata Dos Santos; Joseli Lannes-Vieira
Journal:  PLoS One       Date:  2021-01-05       Impact factor: 3.240

Review 4.  Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care.

Authors:  Roberto M Saraiva; Mauro Felippe F Mediano; Fernanda Sns Mendes; Gilberto Marcelo Sperandio da Silva; Henrique H Veloso; Luiz Henrique C Sangenis; Paula Simplício da Silva; Flavia Mazzoli-Rocha; Andréa S Sousa; Marcelo T Holanda; Alejandro M Hasslocher-Moreno
Journal:  World J Cardiol       Date:  2021-12-26

5.  The effects of the ethanol extract of Cordia myxa leaves on the cognitive function in mice.

Authors:  Gülsen Kendir; Ho Jung Bae; Jihyun Kim; Yongwoo Jeong; Hyo Jeoung Bae; Keontae Park; Xingquan Yang; Young-Jin Cho; Ji-Young Kim; Seo Yun Jung; Ayşegül Köroğlu; Dae Sik Jang; Jong Hoon Ryu
Journal:  BMC Complement Med Ther       Date:  2022-08-10

6.  Acute Chagas disease induces cerebral microvasculopathy in mice.

Authors:  Lindice Mitie Nisimura; Vanessa Estato; Elen Mello de Souza; Patricia A Reis; Marcos Adriano Lessa; Hugo Caire Castro-Faria-Neto; Mirian Claudia de Souza Pereira; Eduardo Tibiriçá; Luciana Ribeiro Garzoni
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

7.  Clinical assessment, neuroimaging and immunomarkers in Chagas disease study (CLINICS): Rationale, study design and preliminary findings.

Authors:  Jamary Oliveira-Filho; Jesângeli de S Dias; Pedro A P Jesus; Nestor J S B Neto; Roque Aras; Francisco J F B Reis; Karen L Furie
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep

8.  Cognitive impairment: an (in)dependent risk factor for mortality in older men?

Authors:  Júlia C Loureiro; Marcos V Pais; Orestes V Forlenza
Journal:  Braz J Psychiatry       Date:  2020 Nov-Dec       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.